pharmaceutical investing AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR® at Psych Congress 2026 18 September
pharmaceutical investing AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society Meeting 17 September
pharmaceutical investing Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications 17 September
